CCMP inks $500m healthcare deal
The firm has purchased an 80% stake in clinical research specialist Medpace, whose management team will own the remaining 20 percent following the close of the transaction.
The firm has purchased an 80% stake in clinical research specialist Medpace, whose management team will own the remaining 20 percent following the close of the transaction.
Copyright PEI Media
Not for publication, email or dissemination